The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

Abroad (travel likely)Recruiting

Conditions

Hemophilia B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Lei Zhang, MD) · zhanglei1@ihcams.ac.cn

Study leads

Lei Zhang, MD
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

Hemophilia B

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tianjin, China

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder

Abroad (travel likely)Recruiting

Phoenix, United States · Little Rock, United States

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Hemophilia B

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Los Angeles, United States

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Healthy Participants · Hemophilia A · Hemophilia B

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Los Angeles, United States